Augustine Therapeutics
Augustine Therapeutics is a neuromuscular drug developer founded in 2019.
2
Funding Rounds
$102.0m
Money raised
Overview
Augustine Therapeutics is a neuromuscular drug developer founded in 2019.
- Website:
- Headquarters: Leuven
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Augustine Therapeutics has raised a total of $102m in funding over 2 rounds.
Key Insights:
- Augustine Therapeutics Series A Round, March 2025: $84m
- Augustine Therapeutics June 2024 Series A Funding Round: $18m
Augustine Therapeutics Series A Round, March 2025
$84m
Augustine Therapeutics June 2024 Series A Funding Round
$18m
Industries
Augustine Therapeutics is active in the following industries: